The role of ifosfamide in cytoreduction, stem cell mobilization and high-dose therapy in relapsed/refractory malignant lymphomas.
Hagemeister
F B
FB
Diehl
V
V
D018906:Antineoplastic Agents, Alkylating / Q000494:pharmacology / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D019650:Hematopoietic Stem Cell Mobilization / Q000379:methods*; D006801:Humans; D007069:Ifosfamide / Q000494:pharmacology / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000494:pharmacology / Q000627:therapeutic use; D008223:Lymphoma / Q000188:drug therapy* / Q000628:therapy; D012008:Recurrence
D018906:Antineoplastic Agents, Alkylating; D007166:Immunosuppressive Agents; D007069:Ifosfamide